A randomized, cross-over study evaluating single- and multiple-daily dosage schedules of ursodeoxycholic acid in primary biliary cirrhosis

被引：0
|
作者：
Angulo, P
Petz, JL
Jorgensen, RA
Lindor, KD
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：A629 / A629
页数：1
相关论文
共 26 条
  • [1] URSODEOXYCHOLIC ACID IN THE MANAGEMENT OF PRIMARY CONSTIPATION - A CROSS-OVER STUDY
    ZAMBONI, L
    TALARICO, R
    LABATE, AMM
    MALAVOLTI, M
    CICOGNANI, C
    SAMA, C
    BARBARA, L
    GASTROENTEROLOGY, 1995, 108 (04) : A1207 - A1207
  • [2] THE EFFECT OF URSODEOXYCHOLIC ACID TREATMENT ON PRIMARY CONSTIPATION - A CROSS-OVER STUDY
    TALARICO, R
    IZAMBONI, L
    MALAVOLTI, M
    CICOGNANI, C
    VENTUROLI, N
    SAMA, C
    BARBARA, L
    GASTROENTEROLOGY, 1994, 106 (04) : A995 - A995
  • [3] URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS - A SHORT-TERM, RANDOMIZED, DOUBLE-BLIND CONTROLLED, CROSS-OVER STUDY WITH LONG-TERM FOLLOW-UP
    HWANG, SJ
    CHAN, CY
    LEE, SD
    WU, JC
    TSAY, SH
    LO, KJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (03) : 217 - 223
  • [4] Comparison between tauroursodeoxycholic and ursodeoxycholic acids in patients with primary biliary cirrhosis: A cross over study.
    Invernizzi, P
    Setchell, KDR
    Crosignani, A
    Larghi, A
    Battezzati, PM
    OConnell, N
    Podda, M
    HEPATOLOGY, 1996, 24 (04) : 166 - 166
  • [5] A randomized controlled trial evaluating therapy with ursodeoxycholic acid in daily doses of 10 mg/kg versus 20 mg/kg in primary biliary cirrhosis.
    van Hoogstraten, HJF
    de Smet, MBM
    Renooij, W
    Hop, WCJ
    van Buuren, HR
    vanBerge-Henegouwen, GP
    GASTROENTEROLOGY, 1998, 114 (04) : A1358 - A1358
  • [6] A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
    Van Hoogstraten, HJF
    De Smet, MBM
    Renooij, W
    Breed, JGS
    Engels, LGJB
    Den Ouden-Muller, JW
    Rijk, MCM
    Smit, AM
    Zwertbroek, R
    Hop, WCJ
    Henegouwen, GPV
    Schalm, SW
    Van Buuren, HR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 965 - 971
  • [7] Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: A prospective randomized study
    Ikeda, T
    Tozuka, S
    Noguchi, O
    Kobayashi, F
    Sakamoto, S
    Marumo, F
    Sato, C
    JOURNAL OF HEPATOLOGY, 1996, 24 (01) : 88 - 94
  • [8] Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis - A Swedish multicentre, double-blind, randomized controlled study
    Eriksson, LS
    Olsson, R
    Glauman, H
    Prytz, H
    Befrits, R
    Ryden, BO
    Einarsson, K
    Lindgren, S
    Wallerstedt, S
    Weden, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (02) : 179 - 186
  • [9] Ursodeoxycholic acid (UDCA) for primary sclerosing cholangitis (PSC): Results of a 2-year randomized controlled trial evaluating single versus multiple daily doses
    vanHoogstraten, HJF
    vandeMeeberg, PC
    Wolfhagen, FHJ
    Kuiper, H
    Hop, WCJ
    vanBergeHenegouwen, GP
    Schalm, SW
    vanBuuren, HR
    HEPATOLOGY, 1997, 26 (04) : 1089 - 1089
  • [10] Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial
    Prince, MI
    Mitchison, HC
    Ashley, D
    Burke, DA
    Edwards, N
    Bramble, MG
    James, OFW
    Jones, DEJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (01) : 137 - 143
123